165 related articles for article (PubMed ID: 2527155)
21. Intravenous and oral MDL 17043 (a new inotrope-vasodilator agent) in congestive heart failure: hemodynamic and clinical evaluation in 38 patients.
Kereiakes D; Chatterjee K; Parmley WW; Atherton B; Curran D; Kereiakes A; Spangenberg R
J Am Coll Cardiol; 1984 Nov; 4(5):884-9. PubMed ID: 6238076
[TBL] [Abstract][Full Text] [Related]
22. Effects of low dose enoximone for chronic congestive heart failure.
Jessup M; Ulrich S; Samaha J; Helfer D
Am J Cardiol; 1987 Aug; 60(5):80C-84C. PubMed ID: 2956875
[TBL] [Abstract][Full Text] [Related]
23. Acute hemodynamic effect of oral MDL 17,043 in severe congestive heart failure.
Uretsky BF; Generalovich T; Reddy PS; Salerni R; Valdes AM; Spangenberg RB; Lang JF; Okerholm RA
Am J Cardiol; 1984 Aug; 54(3):357-62. PubMed ID: 6235735
[TBL] [Abstract][Full Text] [Related]
24. Placebo-controlled study of oral enoximone in congestive heart failure with initial and final intravenous hemodynamic evaluation.
Khalife K; Zannad F; Brunotte F; Belhadj K; Juilliere Y; Iannascoli F; Gilgenkrantz JM
Am J Cardiol; 1987 Aug; 60(5):75C-79C. PubMed ID: 2956874
[TBL] [Abstract][Full Text] [Related]
25. Intravenous use of enoximone.
Crawford MH
Am J Cardiol; 1987 Aug; 60(5):42C-45C. PubMed ID: 2956867
[TBL] [Abstract][Full Text] [Related]
26. Inotropic effect of enoximone in patients with severe heart failure: demonstration by left ventricular end-systolic pressure-volume analysis.
Herrmann HC; Ruddy TD; William G; Strauss HW; Boucher CA; Fifer MA
J Am Coll Cardiol; 1987 May; 9(5):1117-23. PubMed ID: 2952702
[TBL] [Abstract][Full Text] [Related]
27. Combined hemodynamic and scintigraphic assessment of piroximone (MDL 19,205) and comparison with dobutamine and nitroprusside.
Massie BM; Cornyn J; Topic N; Loge D; Podolin RA
Am J Cardiol; 1987 Sep; 60(8):647-53. PubMed ID: 3661429
[TBL] [Abstract][Full Text] [Related]
28. [Enoximone and the therapeutic strategy in patients awaiting emergency cardiac graft].
Dubois-Randé JL; Loisance D; Duval-Moulin AM; Deleuze P; Lellouche D; Tavolaro O; Hittinger L; Benvenuti C; Merlet P; Brun D
Arch Mal Coeur Vaiss; 1989; 82(8):1433-8. PubMed ID: 2529834
[TBL] [Abstract][Full Text] [Related]
29. Hemodynamic advantage of combined administration of oral ibopamine and nitroprusside in patients with ischemic and idiopathic congestive cardiomyopathy.
Dei Cas L; Fappani A; Riva S; Metra M; Cicogna R; Manca C; Visioli O
Clin Cardiol; 1985 Aug; 8(8):427-32. PubMed ID: 4028536
[TBL] [Abstract][Full Text] [Related]
30. Acute hemodynamic response to low dose enoximone (MDL 17,043): an oral dose-range study.
Gilbert EM; Bristow MR; Mason JW
Am J Cardiol; 1987 Aug; 60(5):57C-62C. PubMed ID: 2956870
[TBL] [Abstract][Full Text] [Related]
31. [Role of the enoximone-dobutamine combination in the treatment of congestive cardiac insufficiency].
Richard C; Thuillez C; Annane D; Bellissant E; Teboul JL
Arch Mal Coeur Vaiss; 1990 Sep; 83 Spec No 3():33-7. PubMed ID: 2147832
[TBL] [Abstract][Full Text] [Related]
32. Potentiation of the effects of enoximone by a dobutamine infusion.
Vincent JL; Madhoun P; Primo G; Kahn RJ
Intensive Care Med; 1989; 15(8):530-1. PubMed ID: 2532656
[TBL] [Abstract][Full Text] [Related]
33. Addition of phosphodiesterase inhibitors to adrenergic agents in acutely ill patients.
Vincent JL; Léon M; Berré J; Mélot C; Kahn RJ
Int J Cardiol; 1990 Jul; 28 Suppl 1():S7-11. PubMed ID: 2145239
[TBL] [Abstract][Full Text] [Related]
34. [Long-term therapy of chronic cardiac insufficiency using enoximone].
Treese N; Erbel R; Rhein S; Diefenbach C; Alken RG; Mohr-Kahaly S; Meyer J
Dtsch Med Wochenschr; 1987 Jul; 112(30):1163-9. PubMed ID: 2956080
[TBL] [Abstract][Full Text] [Related]
35. [Comparison of the hemodynamic effect of enoximone and dopamine in patients after coronary bypass operation].
Birnbaum DE; Preuner JG; Gieseke R; Kasper-König W; Trenk D; Jähnchen E; Dieterich HA
Z Kardiol; 1991; 80 Suppl 4():47-52. PubMed ID: 1833897
[TBL] [Abstract][Full Text] [Related]
36. Long-term oral enoximone therapy in chronic cardiac failure.
Maskin CS; Weber KT; Janicki JS
Am J Cardiol; 1987 Aug; 60(5):63C-67C. PubMed ID: 2956871
[TBL] [Abstract][Full Text] [Related]
37. [Hemodynamic effects of enoximone and comparison with dobutamine in patients with chronic respiratory insufficiency and pulmonary arterial hypertension].
Coulaud JM; Faitg R; Poler F; Rezgui N; Besse B; Lissac J
Arch Mal Coeur Vaiss; 1990 Sep; 83 Spec No 3():51-6. PubMed ID: 2147835
[TBL] [Abstract][Full Text] [Related]
38. [Dose-response relation of intravenous enoximone in congestive cardiac insufficiency].
Lellouche D; Delorme G; Merlet P; Dubois-Randé JL; Duval AM; Tarral A; Bourdarias JP; Vernant P
Arch Mal Coeur Vaiss; 1988 Sep; 81(9):1107-13. PubMed ID: 2973777
[TBL] [Abstract][Full Text] [Related]
39. A dose-response study of intravenous enoximone in congestive heart failure.
Erbel R; Meyer J; Diefenbach C; Delorme G; Bourdarias JP; Vernant P; Lellouche D; Mattioli G; Barbieri A; Installe E
Am J Cardiol; 1987 Aug; 60(5):31C-36C. PubMed ID: 2956865
[TBL] [Abstract][Full Text] [Related]
40. [Enoximone in the hemodynamic evaluation before heart transplantation. A new test].
Pornin M; Allal J; Bouton S; Farge D; Couetil JP; Dreyfus G; Sarkis A; Prevost D; Barraine R; Ourbak P
Arch Mal Coeur Vaiss; 1990 Sep; 83 Spec No 3():95-101. PubMed ID: 2147842
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
